Filing Details
- Accession Number:
- 0001181431-13-011855
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-22 16:06:18
- Reporting Period:
- 2013-02-20
- Filing Date:
- 2013-02-22
- Accepted Time:
- 2013-02-22 16:06:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236934 | J Paula Swain | Experimental Station Route 141 &Amp; Henry Clay Road Wilmington DE 19880 | Evp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-20 | 83,033 | $5.46 | 101,094 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-20 | 20,250 | $8.19 | 121,344 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-20 | 103,283 | $21.53 | 18,061 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2013-02-20 | 83,033 | $0.00 | 83,033 | $5.46 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2013-02-20 | 20,250 | $0.00 | 20,250 | $8.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-01-12 | No | 4 | M | Direct | |
| 0 | 2014-02-12 | No | 4 | M | Direct |
Footnotes
- Beginning January 13, 2006 options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remaining vesting monthly over three years.
- Beginning February 13, 2004 options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remaining vesting monthly over three years.
- Represents weighted average sale price. Actual sales prices ranged from $21.32 to $21.65.
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Billionaire Hedge Funds
